The therapeutic effects of tES on brain metabolism are relevant in dementia (61) since the early stage of Alzheimer's disease (AD) shares molecular and cellular features, including insulin resistance and mitochondrial dysfunctions (85), where AD has been called “type 3 diabetes” (86–88). Here, INS is linked to early-onset autosomal dominant Alzheimer disease.